Málstofa: Immunology and infections

Can prime-boost immunization approaches in early life improve immunity against respiratory pathogens?

Can allergy be treated with transgenic barley?

PP2A antagonism and G2/M cell cycle arrest by the maedi-visna virus Vif protein

Long-term use of rituximab increases T cell count in MS patients

PP2A antagonism and G2/M cell cycle arrest by the maedi-visna virus Vif protein

Can prime-boost immunization approaches in early life improve immunity against respiratory pathogens?

Can allergy be treated with transgenic barley?

Long-term use of rituximab increases T cell count in MS patients

Scroll to Top

Á þessu vefsvæði eru notaðar vafrakökur.